维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Lenferink"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Environmental engineering of transition metal dichalcogenide optoelectronics显示文摘	Trevor LaMountain Erik J. Lenferink Yen-Jung Chen Teodor K. Stanev Nathaniel P. Stern	2018	Frontiers of physics2018，13，4：	3
2	Inhibition of HER2/neu and mitogen-activated protein kinases enhances tamoxifen action against HER2 overexpressing , tamoxifen-resistant breast cancer cells显示文摘	Kurokawa H Lenferink AE Simpson JF	2000	Cancer Res2000，1560，20：	1
3	A self- management approach using self- initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and co- morbidities : The COPE - III study protocol 显示文摘	Lenferink A Frith P van der Valk P	2013	Contemp Clin Trials2013，36，1：	1
4	Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies显示文摘	Lenferink AE Cantin C Nantel A	2010	Oncogene2010，29，6：	1
5	Contractivity preserving explicit linear multistep methods显示文摘	Lenferink H W J	1989	Numerische Math- ematik1989，55，2：	1
6	Development of a self- treatment approach for patients with COPD and comorbidities:an on- going learning process 显示文摘	Effing TW Lenferink A Buckman J	2014	J Thorac Dis2014，6，11：	1
7	Erb2/neu kinase modulates cellular P27 and cyclin D1 through multiple signaling pathways显示文摘	Lenferink AE Flanagan WM Yakes FM	2001	Cancer Res2001，61，17：	1
8	A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease(COPD)and comorbidities:the COPE-III study protocol显示文摘	Lenferink Anke Frith Peter van der Valk Paul Buckman Julie Sladek Ruth Cafarella Paul van der Palen Job Effing Tanja	2013	Contemporary clinical trials2013，36，1：	1
9	Transcriptome profilingof a TGF-β-induced epithelial-to-mesenchymal transition revealsextracellular clusterin as a target for therapeutic antibodies显示文摘	Lenferink AE Cantin C Nantel A	2010	Oncogene2010，29，6：	1
10	Identification of high- quality cancer prognosticmarkers and metastasis network modules 显示文摘	Li J Lenferink A E G Deng Y	2010	Nat Commun2010，1，：	1
11	Identification of high- quality cancer prognosticmarkers and metastasis network modules 显示文摘	Li J Lenferink A E G Deng Y	2010	Nat Commun2010，1，：	1
12	Two-level Picard-defect corrections for the Navier-Stokes equations显示文摘	Layton W Lenferink W	1996	SIAM J Numer Anal1996，33，：	1
13	Two-level Picard-defect correc- tions for the Navier-Stokes equations at high Reyn- olds number显示文摘	Layton W Lenferink W	1995	Appl Math Comp1995，69，：	1
14	Cyclin-dependent kinase inhibitor P27(kipl) is required for mouse mammary gland morphogenesis and function显示文摘	Muraka R S Lenferink A E Simpson J	2001	J-Cell-Biol2001，153，5：	1
15	A multi-level mesh indepen- dence principle for the Navier-Stokes equations显示文摘	Layton W Lenferink W	1996	SIAM J Numer Anal1996，33，：	1
16	A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: The COPE-III study protocol显示文摘	Anke Lenferink Peter Frith Paul van der Valk Julie Buckman Ruth Sladek Paul Cafarella Job van der Palen Tanja Effing	2013	Contemporary Clinical Trials2013，，1：	1
17	Pointwise convergence of approximation a convection diffusion equation on a Shishkin mesh显示文摘	LENFERINK H W	2000	Appl Numer Math2000，32，1：	1
18	Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells 显示文摘	Kurokawa H Lenferink AE Simpson JF	2000	Cancer Res2000，60，20：	1
19	Inhibition of HER2/ neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells显示文摘	Kumkawa H Lenferink AE Simpson JF	2000	Cancer Res2000，60，20：	1
20	Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies 显示文摘	Lenferink AE Cantin C Nantel A	2010	Oncogene2010，29，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示